Exenatide(Dongguan baolijian)

艾塞那肽（东莞宝丽健）

Report date: 2025/06/23 14:02:00

Base Information

Drug NameExenatide(Dongguan baolijian)
Drug Alias NameRecombinant exendin 4重组促胰岛素分泌素Recombinant exendin-4艾塞那肽（重组多肽）Recombinant insulin secretagogue +[9] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesDongguan Baolijian Bioengineering Research And Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co LtdDongguan Baolijian Bioengineering Research And Development Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A